KONQUEST: KEPPRA VERSUS OLDER AEDS AND NEUROPSYCHIATRIC, NEUROCOGNITIVE AND QUALITY OF LIFE OUTCOMES IN TREATMENT OF EPILEPSY AS SUBSTITUTION MONOTHERAPY